Minimal Residual Disease MRD Analysis for B-ALL Test
Introduction to MRD Analysis
The Minimal Residual Disease (MRD) Analysis for B-cell Acute Lymphoblastic Leukemia (B-ALL) is a vital diagnostic test that plays a significant role in the management of leukemia. This test helps oncologists assess the effectiveness of treatment by detecting small numbers of leukemia cells that may remain in the body after therapy. Early detection of these residual cells is crucial for preventing relapses and guiding further treatment options.
What the Test Measures
The MRD Analysis employs advanced flow cytometry techniques to measure specific leukemia-associated markers on the surface of cells. It detects minimal residual disease by identifying the following test components:
- CD10
- CD13
- CD15
- CD19
- CD20
- CD33
- CD34
- CD38
- CD45
- CD58
- CD73
- CD86
- CD123
- CD200
- SYTO-16
Who Should Consider This Test?
This test is recommended for patients diagnosed with B-ALL, especially those who have undergone treatment and are in remission. It is particularly important for:
- Patients experiencing symptoms of relapse such as fatigue, fever, or unexplained bruising.
- Individuals with high-risk factors, including age and genetic markers that may indicate a higher likelihood of relapse.
- Patients whose previous immunophenotype reports suggest the need for close monitoring.
Benefits of Taking the Test
Taking the MRD Analysis test offers several benefits, including:
- Early detection of residual leukemia cells, allowing for timely intervention.
- Personalized treatment plans based on individual MRD levels.
- Improved overall outcomes and survival rates for patients with B-ALL.
- Peace of mind for patients and their families by understanding the effectiveness of ongoing treatment.
Understanding Your Results
Results from the MRD Analysis are typically available the next working day. Understanding these results is crucial for both patients and oncologists. A lower MRD level indicates a better response to treatment, while higher levels may necessitate further evaluation and potential adjustments in therapy. It is essential to discuss your results with your healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Minimal Residual Disease MRD Analysis for B-ALL | 280000 NGN | 380000 NGN |
Booking the Test
To book the Minimal Residual Disease MRD Analysis for B-ALL Test, please ensure you provide the following pre-test instructions:
- Date & Time of sampling
- Previous immunophenotype report
- Clinical history
Samples should be collected as follows: 3 mL (1 mL min.) of first pull Bone Marrow aspirate in a Green Top (Sodium Heparin) tube. Ship immediately at 18-22°C. DO NOT FREEZE.
For more information or to schedule your test, please call or WhatsApp us at +2348077798758. Your health is our priority, and we are here to help you every step of the way.
